TLLPharmaceuticals
Trident Lifeline Ltd — PE Ratio & Valuation Analysis
₹268.35
+5.50%
Current P/E22.96xPrice to earnings
Industry P/E31.77xSector average
4Y Avg P/E36.9x37.7% below avg
✅
27.7% Discount to Industry
TLL P/E 22.96x vs sector avg 31.77x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2025 | ₹10.22 | ₹311 | 30.4x |
| 2024 | ₹5.52 | ₹280 | 50.7x |
| 2023 | ₹6.22 | ₹188 | 30.2x |
| 2022 | ₹3.43 | ₹124 | 36.1x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding Trident Lifeline Ltd Valuation
Trident Lifeline Ltd (TLL) currently trades at 22.96x earnings. The Pharmaceuticals sector average PE is 31.77x. TLL is trading at a discount to peers — may indicate relative value. Historically, TLL has traded at an average PE of 36.9x — it is currently below that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
20.02%
Dividend Yield
0.00%
More on Trident Lifeline Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.